The “January – March 2020 | Potential Signals of Serious Risks/New Safety Information Identified by the FDA Adverse Event Reporting System (FAERS)”, which is sometimes called the FDA Watch List, includes an item about all vascular endothelial growth factor inhibitors medicines, i.e., the VEGF inhibitors class of drugs. As regards those VEGF … [Read more...]
Health Canada: OFEV Label Will Add Drug-Induced Liver Injury Warning
On January 11, 2018 Health Canada issued a Dear Healthcare Professional Letter communication titled “OFEV (nintedanib) – Risk of Drug-Induced Liver Injury and the Need for Regular Monitoring of Liver Function”. From the Background Information section of that new Health Canada document we get this overview of the safety issue: OFEV (nintedanib) … [Read more...]